InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Coats Lonnel. Director active across 2 companies, notably Blueprint Medicines Corp. Cumulatively, 15 disclosures have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €224k. History available since 2 June 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Coats Lonnel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
6,144 sharesCommon StockSEC:0001104659-25-069392:0
3,902 shares@ US$12,812.0098.9% of flowCommon StockSEC:0001415889-25-018069:0
7,500 shares@ US$69.791.1% of flowCommon StockSEC:0001415889-24-027545:0
2,242 shares0Common StockSEC:0001415889-24-016985:0
33,333 sharesCommon StockSEC:0001127602-24-007612:0
90,000 shares@ US$1.053339.0% of flowCommon StockSEC:0001127602-23-027850:0
Canonical exit: 14 Feb 2024 (T+90)
10,000 shares@ US$1.014.2% of flowCommon StockSEC:0001127602-23-027279:0
Canonical exit: 8 Feb 2024 (T+90)
10,000 shares@ US$2.168.9% of flowCommon StockSEC:0001127602-23-019560:0
Canonical exit: 27 Sept 2023 (T+90)
10,000 shares@ US$2.49510.2% of flowCommon StockSEC:0001127602-23-019405:0
Canonical exit: 21 Sept 2023 (T+90)
2,600 shares0Common StockSEC:0001415889-23-010259:0
40,000 shares@ US$2.3137.7% of flowCommon StockSEC:0001127602-23-019231:0
Canonical exit: 20 Sept 2023 (T+90)
84,630 sharesCommon StockSEC:0001127602-23-007915:0
2,600 shares0Common StockSEC:0001415889-22-007133:0
79,380 sharesCommon StockSEC:0001127602-22-007167:0
2,250 shares0Common StockSEC:0001179110-21-006419:0
15 of 15 declarations
About Coats Lonnel
COATS LONNEL is a declarant linked to Lexicon Pharmaceuticals, INC. as Chief Executive Officer and to Blueprint Medicines Corp as Director. He has 15 filings in total, and across the 15 sampled filings between 2021-06-04 and 2025-07-21, buys total 223758 EUR and sells 0 EUR, with transaction nature indicated as Attribution.
